Nintedanib (BIBF 1120) is a Tyrosine Kinase/Triple Angiokinase Inhibitor
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD). Hence, the characteristics of IPF is self-sustaining fibrosis, deteriorating lung function, worsening symptoms (e.g. dyspnoea, cough), increasingly impaired…